Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1-Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression.
about
The treatment of hyperinsulinemic hypoglycaemia in adults: an update.A MEN1 pancreatic neuroendocrine tumour mouse model under temporal control.The future: genetics advances in MEN1 therapeutic approaches and management strategies.New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects.
P2860
Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1-Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pasireotide Therapy of Multipl ...... and Reduces Tumor Progression.
@en
type
label
Pasireotide Therapy of Multipl ...... and Reduces Tumor Progression.
@en
prefLabel
Pasireotide Therapy of Multipl ...... and Reduces Tumor Progression.
@en
P2093
P2860
P356
P1433
P1476
Pasireotide Therapy of Multipl ...... and Reduces Tumor Progression.
@en
P2093
Ashley B Grossman
Benjamin S Soukup
Gerard V Walls
Herbert A Schmid
Mark Stevenson
P2860
P304
P356
10.1210/EN.2015-1965
P407
P577
2016-03-18T00:00:00Z